2026-05-28, 6:00:07 a.m.
BOCA RATON, Fla. — May 28, 2026 — Leads & Copy —
Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) has applied to the U.S. Drug Enforcement Administration (DEA) for registration of certain state-licensed medical marijuana operations. The applications follow the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.
Jim Cacioppo, Chief Executive Officer of Jushi, stated that pursuing DEA registration is an important milestone for Jushi and the medical patients they serve. He added that the company is focused on operating at the highest regulatory standards and believes this process represents a meaningful step toward a more integrated and transparent national framework for medical cannabis.
The DEA introduced a streamlined registration pathway for qualified state-licensed medical marijuana operators in connection with the reclassification of medical marijuana produced by these operators to Schedule III. The process allows applicants to seek federal registration related to the manufacture, distribution, and dispensing of Schedule III medical cannabis products, while relying on existing state medical licenses as part of the qualification process. Registrations may be granted on an expedited basis for operators that submit applications within the initial 60-day filing window, unless otherwise notified by the DEA.
Jushi believes this framework shows growing federal recognition of the strength and oversight of state medical cannabis programs. The company also believes it provides a pathway toward greater alignment between state and federal regulation. Jushi’s applications are intended to position the company to participate in this evolving regulatory structure while continuing to serve medical patients in accordance with applicable state laws.
Cacioppo also noted the importance of this step for the industry. He added that it reinforces what the company has heard from patients about their experience with medical cannabis. Cacioppo stated that Jushi looks forward to engaging with regulators as this framework develops and supporting continued progress in research, patient access, and responsible oversight of medical cannabis in the United States.
Jushi is a vertically integrated cannabis company focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts, and competitive applications. The company aims to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem.
